KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Receivables (2016 - 2025)

Historic Receivables for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to $2.7 billion.

  • Humana's Receivables rose 2518.66% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year increase of 2518.66%. This contributed to the annual value of $2.9 billion for FY2024, which is 3002.72% up from last year.
  • Per Humana's latest filing, its Receivables stood at $2.7 billion for Q3 2025, which was up 2518.66% from $4.5 billion recorded in Q2 2025.
  • Over the past 5 years, Humana's Receivables peaked at $4.5 billion during Q2 2025, and registered a low of $1.4 billion during Q2 2023.
  • Moreover, its 5-year median value for Receivables was $2.4 billion (2021), whereas its average is $2.7 billion.
  • Its Receivables has fluctuated over the past 5 years, first tumbled by 5758.39% in 2023, then skyrocketed by 18621.41% in 2024.
  • Humana's Receivables (Quarter) stood at $2.0 billion in 2021, then dropped by 7.34% to $1.9 billion in 2022, then rose by 19.03% to $2.2 billion in 2023, then surged by 30.03% to $2.9 billion in 2024, then fell by 6.51% to $2.7 billion in 2025.
  • Its last three reported values are $2.7 billion in Q3 2025, $4.5 billion for Q2 2025, and $4.5 billion during Q1 2025.